Inhibitors was valued at US$ 354 million in the year 2024 and is projected to reach a revised size of US$ 458 million by 2031, growing at a CAGR of 3.9% during the forecast period.

Monoamine Oxidase Type B (MAO-BI) Inhibitors Market

The global market for Monoamine Oxidase Type B (MAO-BI)

Monoamine Oxidase Type B Inhibitors (MAO-BIs) are a class of drugs that selectively inhibit the activity of the monoamine oxidase B enzyme, which is responsible for breaking down dopamine in the brain. By preventing dopamine degradation, MAO-B inhibitors help increase dopamine levels, making them effective in the treatment of neurodegenerative disorders such as Parkinson’s disease. Common MAO-B inhibitors include selegiline, rasagiline. These drugs are often used alone in the early stages of Parkinson’s or in combination with other treatments to enhance their therapeutic effects.

North American market for Monoamine Oxidase Type B (MAO-BI) Inhibitors is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Monoamine Oxidase Type B (MAO-BI) Inhibitors is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Monoamine Oxidase Type B (MAO-BI) Inhibitors in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Monoamine Oxidase Type B (MAO-BI) Inhibitors include Fujimoto, Orion Corporation, Viatris, chiesi, Apotex, Lvye Pharma, Abbott, Kyowa Pharmaceutical, Bausch Health, Intas Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Monoamine Oxidase Type B (MAO-BI) Inhibitors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Monoamine Oxidase Type B (MAO-BI) Inhibitors.

The Monoamine Oxidase Type B (MAO-BI) Inhibitors market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Monoamine Oxidase Type B (MAO-BI) Inhibitors market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Monoamine Oxidase Type B (MAO-BI) Inhibitors companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Report

Report Metric	Details
Report Name	Monoamine Oxidase Type B (MAO-BI) Inhibitors Market
Accounted market size in year	US$ 354 million
Forecasted market size in 2031	US$ 458 million
CAGR	3.9%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Selegiline Rasagiline
Segment by Application	Hospital Retail Pharmacy Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Fujimoto, Orion Corporation, Viatris, chiesi, Apotex, Lvye Pharma, Abbott, Kyowa Pharmaceutical, Bausch Health, Intas Pharmaceutical, Teva, Takeda Pharmaceutical, Qilu Pharma, Lundbeck A/S, Sun Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Monoamine Oxidase Type B (MAO-BI) Inhibitors company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Monoamine Oxidase Type B (MAO-BI) Inhibitors Market growing?

Ans: The Monoamine Oxidase Type B (MAO-BI) Inhibitors Market witnessing a CAGR of 3.9% during the forecast period 2025-2031.

What is the Monoamine Oxidase Type B (MAO-BI) Inhibitors Market size in 2031?

Ans: The Monoamine Oxidase Type B (MAO-BI) Inhibitors Market size in 2031 will be US$ 458 million.

Who are the main players in the Monoamine Oxidase Type B (MAO-BI) Inhibitors Market report?

Ans: The main players in the Monoamine Oxidase Type B (MAO-BI) Inhibitors Market are Fujimoto, Orion Corporation, Viatris, chiesi, Apotex, Lvye Pharma, Abbott, Kyowa Pharmaceutical, Bausch Health, Intas Pharmaceutical, Teva, Takeda Pharmaceutical, Qilu Pharma, Lundbeck A/S, Sun Pharmaceutical

What are the Application segmentation covered in the Monoamine Oxidase Type B (MAO-BI) Inhibitors Market report?

Ans: The Applications covered in the Monoamine Oxidase Type B (MAO-BI) Inhibitors Market report are Hospital, Retail Pharmacy, Other

What are the Type segmentation covered in the Monoamine Oxidase Type B (MAO-BI) Inhibitors Market report?

Ans: The Types covered in the Monoamine Oxidase Type B (MAO-BI) Inhibitors Market report are Selegiline, Rasagiline

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Selegiline

1.2.3 Rasagiline

1.3 Market by Application

1.3.1 Global Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Retail Pharmacy

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Perspective (2020-2031)

2.2 Global Monoamine Oxidase Type B (MAO-BI) Inhibitors Growth Trends by Region

2.2.1 Global Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Monoamine Oxidase Type B (MAO-BI) Inhibitors Historic Market Size by Region (2020-2025)

2.2.3 Monoamine Oxidase Type B (MAO-BI) Inhibitors Forecasted Market Size by Region (2026-2031)

2.3 Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Dynamics

2.3.1 Monoamine Oxidase Type B (MAO-BI) Inhibitors Industry Trends

2.3.2 Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Drivers

2.3.3 Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Challenges

2.3.4 Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Monoamine Oxidase Type B (MAO-BI) Inhibitors Players by Revenue

3.1.1 Global Top Monoamine Oxidase Type B (MAO-BI) Inhibitors Players by Revenue (2020-2025)

3.1.2 Global Monoamine Oxidase Type B (MAO-BI) Inhibitors Revenue Market Share by Players (2020-2025)

3.2 Global Top Monoamine Oxidase Type B (MAO-BI) Inhibitors Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Monoamine Oxidase Type B (MAO-BI) Inhibitors Revenue

3.4 Global Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Concentration Ratio

3.4.1 Global Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Monoamine Oxidase Type B (MAO-BI) Inhibitors Revenue in 2024

3.5 Global Key Players of Monoamine Oxidase Type B (MAO-BI) Inhibitors Head office and Area Served

3.6 Global Key Players of Monoamine Oxidase Type B (MAO-BI) Inhibitors, Product and Application

3.7 Global Key Players of Monoamine Oxidase Type B (MAO-BI) Inhibitors, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Monoamine Oxidase Type B (MAO-BI) Inhibitors Breakdown Data by Type

4.1 Global Monoamine Oxidase Type B (MAO-BI) Inhibitors Historic Market Size by Type (2020-2025)

4.2 Global Monoamine Oxidase Type B (MAO-BI) Inhibitors Forecasted Market Size by Type (2026-2031)

5 Monoamine Oxidase Type B (MAO-BI) Inhibitors Breakdown Data by Application

5.1 Global Monoamine Oxidase Type B (MAO-BI) Inhibitors Historic Market Size by Application (2020-2025)

5.2 Global Monoamine Oxidase Type B (MAO-BI) Inhibitors Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size (2020-2031)

6.2 North America Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size by Country (2020-2025)

6.4 North America Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size (2020-2031)

7.2 Europe Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size by Country (2020-2025)

7.4 Europe Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size (2020-2031)

8.2 Asia-Pacific Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size by Region (2020-2025)

8.4 Asia-Pacific Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size (2020-2031)

9.2 Latin America Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size by Country (2020-2025)

9.4 Latin America Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size (2020-2031)

10.2 Middle East & Africa Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size by Country (2020-2025)

10.4 Middle East & Africa Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Fujimoto

11.1.1 Fujimoto Company Details

11.1.2 Fujimoto Business Overview

11.1.3 Fujimoto Monoamine Oxidase Type B (MAO-BI) Inhibitors Introduction

11.1.4 Fujimoto Revenue in Monoamine Oxidase Type B (MAO-BI) Inhibitors Business (2020-2025)

11.1.5 Fujimoto Recent Development

11.2 Orion Corporation

11.2.1 Orion Corporation Company Details

11.2.2 Orion Corporation Business Overview

11.2.3 Orion Corporation Monoamine Oxidase Type B (MAO-BI) Inhibitors Introduction

11.2.4 Orion Corporation Revenue in Monoamine Oxidase Type B (MAO-BI) Inhibitors Business (2020-2025)

11.2.5 Orion Corporation Recent Development

11.3 Viatris

11.3.1 Viatris Company Details

11.3.2 Viatris Business Overview

11.3.3 Viatris Monoamine Oxidase Type B (MAO-BI) Inhibitors Introduction

11.3.4 Viatris Revenue in Monoamine Oxidase Type B (MAO-BI) Inhibitors Business (2020-2025)

11.3.5 Viatris Recent Development

11.4 chiesi

11.4.1 chiesi Company Details

11.4.2 chiesi Business Overview

11.4.3 chiesi Monoamine Oxidase Type B (MAO-BI) Inhibitors Introduction

11.4.4 chiesi Revenue in Monoamine Oxidase Type B (MAO-BI) Inhibitors Business (2020-2025)

11.4.5 chiesi Recent Development

11.5 Apotex

11.5.1 Apotex Company Details

11.5.2 Apotex Business Overview

11.5.3 Apotex Monoamine Oxidase Type B (MAO-BI) Inhibitors Introduction

11.5.4 Apotex Revenue in Monoamine Oxidase Type B (MAO-BI) Inhibitors Business (2020-2025)

11.5.5 Apotex Recent Development

11.6 Lvye Pharma

11.6.1 Lvye Pharma Company Details

11.6.2 Lvye Pharma Business Overview

11.6.3 Lvye Pharma Monoamine Oxidase Type B (MAO-BI) Inhibitors Introduction

11.6.4 Lvye Pharma Revenue in Monoamine Oxidase Type B (MAO-BI) Inhibitors Business (2020-2025)

11.6.5 Lvye Pharma Recent Development

11.7 Abbott

11.7.1 Abbott Company Details

11.7.2 Abbott Business Overview

11.7.3 Abbott Monoamine Oxidase Type B (MAO-BI) Inhibitors Introduction

11.7.4 Abbott Revenue in Monoamine Oxidase Type B (MAO-BI) Inhibitors Business (2020-2025)

11.7.5 Abbott Recent Development

11.8 Kyowa Pharmaceutical

11.8.1 Kyowa Pharmaceutical Company Details

11.8.2 Kyowa Pharmaceutical Business Overview

11.8.3 Kyowa Pharmaceutical Monoamine Oxidase Type B (MAO-BI) Inhibitors Introduction

11.8.4 Kyowa Pharmaceutical Revenue in Monoamine Oxidase Type B (MAO-BI) Inhibitors Business (2020-2025)

11.8.5 Kyowa Pharmaceutical Recent Development

11.9 Bausch Health

11.9.1 Bausch Health Company Details

11.9.2 Bausch Health Business Overview

11.9.3 Bausch Health Monoamine Oxidase Type B (MAO-BI) Inhibitors Introduction

11.9.4 Bausch Health Revenue in Monoamine Oxidase Type B (MAO-BI) Inhibitors Business (2020-2025)

11.9.5 Bausch Health Recent Development

11.10 Intas Pharmaceutical

11.10.1 Intas Pharmaceutical Company Details

11.10.2 Intas Pharmaceutical Business Overview

11.10.3 Intas Pharmaceutical Monoamine Oxidase Type B (MAO-BI) Inhibitors Introduction

11.10.4 Intas Pharmaceutical Revenue in Monoamine Oxidase Type B (MAO-BI) Inhibitors Business (2020-2025)

11.10.5 Intas Pharmaceutical Recent Development

11.11 Teva

11.11.1 Teva Company Details

11.11.2 Teva Business Overview

11.11.3 Teva Monoamine Oxidase Type B (MAO-BI) Inhibitors Introduction

11.11.4 Teva Revenue in Monoamine Oxidase Type B (MAO-BI) Inhibitors Business (2020-2025)

11.11.5 Teva Recent Development

11.12 Takeda Pharmaceutical

11.12.1 Takeda Pharmaceutical Company Details

11.12.2 Takeda Pharmaceutical Business Overview

11.12.3 Takeda Pharmaceutical Monoamine Oxidase Type B (MAO-BI) Inhibitors Introduction

11.12.4 Takeda Pharmaceutical Revenue in Monoamine Oxidase Type B (MAO-BI) Inhibitors Business (2020-2025)

11.12.5 Takeda Pharmaceutical Recent Development

11.13 Qilu Pharma

11.13.1 Qilu Pharma Company Details

11.13.2 Qilu Pharma Business Overview

11.13.3 Qilu Pharma Monoamine Oxidase Type B (MAO-BI) Inhibitors Introduction

11.13.4 Qilu Pharma Revenue in Monoamine Oxidase Type B (MAO-BI) Inhibitors Business (2020-2025)

11.13.5 Qilu Pharma Recent Development

11.14 Lundbeck A/S

11.14.1 Lundbeck A/S Company Details

11.14.2 Lundbeck A/S Business Overview

11.14.3 Lundbeck A/S Monoamine Oxidase Type B (MAO-BI) Inhibitors Introduction

11.14.4 Lundbeck A/S Revenue in Monoamine Oxidase Type B (MAO-BI) Inhibitors Business (2020-2025)

11.14.5 Lundbeck A/S Recent Development

11.15 Sun Pharmaceutical

11.15.1 Sun Pharmaceutical Company Details

11.15.2 Sun Pharmaceutical Business Overview

11.15.3 Sun Pharmaceutical Monoamine Oxidase Type B (MAO-BI) Inhibitors Introduction

11.15.4 Sun Pharmaceutical Revenue in Monoamine Oxidase Type B (MAO-BI) Inhibitors Business (2020-2025)

11.15.5 Sun Pharmaceutical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Takeda Pharmaceutical

List of Tables

Table 1. Global Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Selegiline

Table 3. Key Players of Rasagiline

Table 4. Global Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Share by Region (2020-2025)

Table 8. Global Monoamine Oxidase Type B (MAO-BI) Inhibitors Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Share by Region (2026-2031)

Table 10. Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Trends

Table 11. Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Drivers

Table 12. Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Challenges

Table 13. Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Restraints

Table 14. Global Monoamine Oxidase Type B (MAO-BI) Inhibitors Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Share by Players (2020-2025)

Table 16. Global Top Monoamine Oxidase Type B (MAO-BI) Inhibitors Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoamine Oxidase Type B (MAO-BI) Inhibitors as of 2024)

Table 17. Ranking of Global Top Monoamine Oxidase Type B (MAO-BI) Inhibitors Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Monoamine Oxidase Type B (MAO-BI) Inhibitors Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Monoamine Oxidase Type B (MAO-BI) Inhibitors, Headquarters and Area Served

Table 20. Global Key Players of Monoamine Oxidase Type B (MAO-BI) Inhibitors, Product and Application

Table 21. Global Key Players of Monoamine Oxidase Type B (MAO-BI) Inhibitors, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Monoamine Oxidase Type B (MAO-BI) Inhibitors Revenue Market Share by Type (2020-2025)

Table 25. Global Monoamine Oxidase Type B (MAO-BI) Inhibitors Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Monoamine Oxidase Type B (MAO-BI) Inhibitors Revenue Market Share by Type (2026-2031)

Table 27. Global Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Monoamine Oxidase Type B (MAO-BI) Inhibitors Revenue Market Share by Application (2020-2025)

Table 29. Global Monoamine Oxidase Type B (MAO-BI) Inhibitors Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Monoamine Oxidase Type B (MAO-BI) Inhibitors Revenue Market Share by Application (2026-2031)

Table 31. North America Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size by Country (2026-2031) & (US$ Million)

Table 46. Fujimoto Company Details

Table 47. Fujimoto Business Overview

Table 48. Fujimoto Monoamine Oxidase Type B (MAO-BI) Inhibitors Product

Table 49. Fujimoto Revenue in Monoamine Oxidase Type B (MAO-BI) Inhibitors Business (2020-2025) & (US$ Million)

Table 50. Fujimoto Recent Development

Table 51. Orion Corporation Company Details

Table 52. Orion Corporation Business Overview

Table 53. Orion Corporation Monoamine Oxidase Type B (MAO-BI) Inhibitors Product

Table 54. Orion Corporation Revenue in Monoamine Oxidase Type B (MAO-BI) Inhibitors Business (2020-2025) & (US$ Million)

Table 55. Orion Corporation Recent Development

Table 56. Viatris Company Details

Table 57. Viatris Business Overview

Table 58. Viatris Monoamine Oxidase Type B (MAO-BI) Inhibitors Product

Table 59. Viatris Revenue in Monoamine Oxidase Type B (MAO-BI) Inhibitors Business (2020-2025) & (US$ Million)

Table 60. Viatris Recent Development

Table 61. chiesi Company Details

Table 62. chiesi Business Overview

Table 63. chiesi Monoamine Oxidase Type B (MAO-BI) Inhibitors Product

Table 64. chiesi Revenue in Monoamine Oxidase Type B (MAO-BI) Inhibitors Business (2020-2025) & (US$ Million)

Table 65. chiesi Recent Development

Table 66. Apotex Company Details

Table 67. Apotex Business Overview

Table 68. Apotex Monoamine Oxidase Type B (MAO-BI) Inhibitors Product

Table 69. Apotex Revenue in Monoamine Oxidase Type B (MAO-BI) Inhibitors Business (2020-2025) & (US$ Million)

Table 70. Apotex Recent Development

Table 71. Lvye Pharma Company Details

Table 72. Lvye Pharma Business Overview

Table 73. Lvye Pharma Monoamine Oxidase Type B (MAO-BI) Inhibitors Product

Table 74. Lvye Pharma Revenue in Monoamine Oxidase Type B (MAO-BI) Inhibitors Business (2020-2025) & (US$ Million)

Table 75. Lvye Pharma Recent Development

Table 76. Abbott Company Details

Table 77. Abbott Business Overview

Table 78. Abbott Monoamine Oxidase Type B (MAO-BI) Inhibitors Product

Table 79. Abbott Revenue in Monoamine Oxidase Type B (MAO-BI) Inhibitors Business (2020-2025) & (US$ Million)

Table 80. Abbott Recent Development

Table 81. Kyowa Pharmaceutical Company Details

Table 82. Kyowa Pharmaceutical Business Overview

Table 83. Kyowa Pharmaceutical Monoamine Oxidase Type B (MAO-BI) Inhibitors Product

Table 84. Kyowa Pharmaceutical Revenue in Monoamine Oxidase Type B (MAO-BI) Inhibitors Business (2020-2025) & (US$ Million)

Table 85. Kyowa Pharmaceutical Recent Development

Table 86. Bausch Health Company Details

Table 87. Bausch Health Business Overview

Table 88. Bausch Health Monoamine Oxidase Type B (MAO-BI) Inhibitors Product

Table 89. Bausch Health Revenue in Monoamine Oxidase Type B (MAO-BI) Inhibitors Business (2020-2025) & (US$ Million)

Table 90. Bausch Health Recent Development

Table 91. Intas Pharmaceutical Company Details

Table 92. Intas Pharmaceutical Business Overview

Table 93. Intas Pharmaceutical Monoamine Oxidase Type B (MAO-BI) Inhibitors Product

Table 94. Intas Pharmaceutical Revenue in Monoamine Oxidase Type B (MAO-BI) Inhibitors Business (2020-2025) & (US$ Million)

Table 95. Intas Pharmaceutical Recent Development

Table 96. Teva Company Details

Table 97. Teva Business Overview

Table 98. Teva Monoamine Oxidase Type B (MAO-BI) Inhibitors Product

Table 99. Teva Revenue in Monoamine Oxidase Type B (MAO-BI) Inhibitors Business (2020-2025) & (US$ Million)

Table 100. Teva Recent Development

Table 101. Takeda Pharmaceutical Company Details

Table 102. Takeda Pharmaceutical Business Overview

Table 103. Takeda Pharmaceutical Monoamine Oxidase Type B (MAO-BI) Inhibitors Product

Table 104. Takeda Pharmaceutical Revenue in Monoamine Oxidase Type B (MAO-BI) Inhibitors Business (2020-2025) & (US$ Million)

Table 105. Takeda Pharmaceutical Recent Development

Table 106. Qilu Pharma Company Details

Table 107. Qilu Pharma Business Overview

Table 108. Qilu Pharma Monoamine Oxidase Type B (MAO-BI) Inhibitors Product

Table 109. Qilu Pharma Revenue in Monoamine Oxidase Type B (MAO-BI) Inhibitors Business (2020-2025) & (US$ Million)

Table 110. Qilu Pharma Recent Development

Table 111. Lundbeck A/S Company Details

Table 112. Lundbeck A/S Business Overview

Table 113. Lundbeck A/S Monoamine Oxidase Type B (MAO-BI) Inhibitors Product

Table 114. Lundbeck A/S Revenue in Monoamine Oxidase Type B (MAO-BI) Inhibitors Business (2020-2025) & (US$ Million)

Table 115. Lundbeck A/S Recent Development

Table 116. Sun Pharmaceutical Company Details

Table 117. Sun Pharmaceutical Business Overview

Table 118. Sun Pharmaceutical Monoamine Oxidase Type B (MAO-BI) Inhibitors Product

Table 119. Sun Pharmaceutical Revenue in Monoamine Oxidase Type B (MAO-BI) Inhibitors Business (2020-2025) & (US$ Million)

Table 120. Sun Pharmaceutical Recent Development

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

Table 124. Authors List of This Report

List of Figures

Figure 1. Monoamine Oxidase Type B (MAO-BI) Inhibitors Picture

Figure 2. Global Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Share by Type: 2024 VS 2031

Figure 4. Selegiline Features

Figure 5. Rasagiline Features

Figure 6. Global Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Share by Application: 2024 VS 2031

Figure 8. Hospital Case Studies

Figure 9. Retail Pharmacy Case Studies

Figure 10. Other Case Studies

Figure 11. Monoamine Oxidase Type B (MAO-BI) Inhibitors Report Years Considered

Figure 12. Global Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Share by Region: 2024 VS 2031

Figure 15. Global Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Share by Players in 2024

Figure 16. Global Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 17. The Top 10 and 5 Players Market Share by Monoamine Oxidase Type B (MAO-BI) Inhibitors Revenue in 2024

Figure 18. North America Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Share by Country (2020-2031)

Figure 20. United States Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Share by Country (2020-2031)

Figure 24. Germany Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Share by Region (2020-2031)

Figure 32. China Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Share by Country (2020-2031)

Figure 40. Mexico Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Share by Country (2020-2031)

Figure 44. Turkey Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Monoamine Oxidase Type B (MAO-BI) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Fujimoto Revenue Growth Rate in Monoamine Oxidase Type B (MAO-BI) Inhibitors Business (2020-2025)

Figure 48. Orion Corporation Revenue Growth Rate in Monoamine Oxidase Type B (MAO-BI) Inhibitors Business (2020-2025)

Figure 49. Viatris Revenue Growth Rate in Monoamine Oxidase Type B (MAO-BI) Inhibitors Business (2020-2025)

Figure 50. chiesi Revenue Growth Rate in Monoamine Oxidase Type B (MAO-BI) Inhibitors Business (2020-2025)

Figure 51. Apotex Revenue Growth Rate in Monoamine Oxidase Type B (MAO-BI) Inhibitors Business (2020-2025)

Figure 52. Lvye Pharma Revenue Growth Rate in Monoamine Oxidase Type B (MAO-BI) Inhibitors Business (2020-2025)

Figure 53. Abbott Revenue Growth Rate in Monoamine Oxidase Type B (MAO-BI) Inhibitors Business (2020-2025)

Figure 54. Kyowa Pharmaceutical Revenue Growth Rate in Monoamine Oxidase Type B (MAO-BI) Inhibitors Business (2020-2025)

Figure 55. Bausch Health Revenue Growth Rate in Monoamine Oxidase Type B (MAO-BI) Inhibitors Business (2020-2025)

Figure 56. Intas Pharmaceutical Revenue Growth Rate in Monoamine Oxidase Type B (MAO-BI) Inhibitors Business (2020-2025)

Figure 57. Teva Revenue Growth Rate in Monoamine Oxidase Type B (MAO-BI) Inhibitors Business (2020-2025)

Figure 58. Takeda Pharmaceutical Revenue Growth Rate in Monoamine Oxidase Type B (MAO-BI) Inhibitors Business (2020-2025)

Figure 59. Qilu Pharma Revenue Growth Rate in Monoamine Oxidase Type B (MAO-BI) Inhibitors Business (2020-2025)

Figure 60. Lundbeck A/S Revenue Growth Rate in Monoamine Oxidase Type B (MAO-BI) Inhibitors Business (2020-2025)

Figure 61. Sun Pharmaceutical Revenue Growth Rate in Monoamine Oxidase Type B (MAO-BI) Inhibitors Business (2020-2025)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Monoamine Oxidase Inhibitors MAOIs Medications Market Research Report 2024

Monoamine Oxidase Inhibitor Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Monoamine Oxidase B Market Research Report 2025

Global Rasagiline Mesylate API Market Research Report 2025

Global Selegiline Hydrochloride Market Research Report 2024

Global Moclobemide Tablet Market Research Report 2025

Global Reversible Inhibitors of Monoamine RIMA Antidepressants Market Research Report 2024

Global Azilect Market Research Report 2024

Global DOPA Decarboxylase Inhibitors Market Research Report 2025

Selegiline Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oral Antiparkinsonian Drugs Market Research Report 2024

Global Rasagiline Mesylate Tablets Market Research Report 2024

Global Norepinephrine Reuptake Inhibitors Market Research Report 2024

Global Oral Parkinson s Disease Medications Market Research Report 2024

Global Parkinson Disease Drug Market Insights Forecast to 2030

Global Peripheral Decarboxylase Inhibitors Market Research Report 2025

Global Compound Levodopa Market Research Report 2025

Global Selective Serotonin Reuptake Inhibitor Drugs Market Research Report 2024

Global Aminic Antioxidants Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions